Logo image
Convulsive seizures from experimental focal cortical dysplasia occur independently of cell misplacement
Journal article   Open access   Peer reviewed

Convulsive seizures from experimental focal cortical dysplasia occur independently of cell misplacement

Lawrence S Hsieh, John H Wen, Kumiko Claycomb, Yuegao Huang, Felicia A Harrsch, Janice R Naegele, Fahmeed Hyder, Gordon F Buchanan and Angelique Bordey
Nature communications, Vol.7(1), pp.11753-11753
06/01/2016
DOI: 10.1038/ncomms11753
PMCID: PMC4895394
PMID: 27249187
url
https://doi.org/10.1038/ncomms11753View
Published (Version of record) Open Access

Abstract

Focal cortical dysplasia (FCD), a local malformation of cortical development, is the most common cause of pharmacoresistant epilepsy associated with life-long neurocognitive impairments. It remains unclear whether neuronal misplacement is required for seizure activity. Here we show that dyslamination and white matter heterotopia are not necessary for seizure generation in a murine model of type II FCDs. These experimental FCDs generated by increasing mTOR activity in layer 2/3 neurons of the medial prefrontal cortex are associated with tonic-clonic seizures and a normal survival rate. Preventing all FCD-related defects, including neuronal misplacement and dysmorphogenesis, with rapamycin treatments from birth eliminates seizures, but seizures recur after rapamycin withdrawal. In addition, bypassing neuronal misplacement and heterotopia using inducible vectors do not prevent seizure occurrence. Collectively, data obtained using our new experimental FCD-associated epilepsy suggest that life-long treatment to reduce neuronal dysmorphogenesis is required to suppress seizures in individuals with FCD.

Details

Metrics

Logo image